Corneodesmosin antibody
Quick Overview for Corneodesmosin antibody (ABIN1106821)
Target
See all Corneodesmosin (CDSN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- This antibody reacts with Human 51 kDa CDSN protein. May cross react with proteins from other species.
-
Purification
- Affinity Chromatography on Protein A
-
Immunogen
- Synthetic peptide derived from N-termiknal domain of Human CDSN.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.1 M Tris, 0.1 M Glycine and 2 % Sucrose, 0.02 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Corneodesmosin (CDSN)
-
Alternative Name
- Corneodesmosin / CDSN
-
Background
- Defects in CDSN are a cause of hypotrichosis simplex of the scalp (HTSS) [MIM:146520], also known as hypotrichosis Spanish type. HTSS is an autosomal dominant form of isolated alopecia. Affected individuals have normal hair in early childhood but experience progressive loss of scalp hair beginning in the middle of the first decade and almost complete baldness by the third decade. Defects in CDSN are the cause of peeling skin syndrome type B (BPSS) [MIM:270300], also known as peeling skin syndrome or deciduous skin or keratolysis exfoliativa congenita. BPSS is a genodermatosis characterized by the continuous shedding of the outer layers of the epidermis, associated with pruritus and atopy. It is an ichthyosiform erythroderma characterized by lifelong patchy peeling of the entire skin with onset at birth or shortly thereafter. Several patients have been reported with high IgE levels.Synonyms: S protein
-
Gene ID
- 1041
-
NCBI Accession
- NP_001255
Target
-